These findings suggest that Triptolide could inhibit IL-1β-induced endothelial angiogenesis by suppressing IL-8 expression in gastric cancer AGS cells, thus having a potential impact on the tumor microenvironment. This evidence concerns the gene IL1B and gastric cancer.